Annual D&A
$177.40 K
+$170.70 K+2547.76%
31 December 2023
Summary:
Inhibikase Therapeutics annual depreciation & amortization is currently $177.40 thousand, with the most recent change of +$170.70 thousand (+2547.76%) on 31 December 2023. IKT annual D&A is now at all-time high.IKT Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$6600.00
$0.000.00%
30 September 2024
Summary:
Inhibikase Therapeutics quarterly depreciation & amortization is currently $6600.00, unchanged on 30 September 2024. Over the past year, it has stayed the same.IKT quarterly D&A is now -95.85% below its all-time high of $159.20 thousand, reached on 30 June 2023.IKT Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$26.40 K
$0.000.00%
30 September 2024
Summary:
Inhibikase Therapeutics TTM depreciation & amortization is currently $26.40 thousand, unchanged on 30 September 2024. Over the past year, it has dropped by -$149.40 thousand (-84.98%). IKT TTM D&A is now -85.25% below its all-time high of $179.00 thousand, reached on 31 March 2024.IKT TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IKT Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2547.8% | 0.0% | -85.0% |
| 3 y3 years | - | +100.0% | +100.0% |
| 5 y5 years | - | - | - |
IKT Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | -95.8% | -85.3% | |||
| 5 y | 5 years | at high | -95.8% | -85.3% | |||
| alltime | all time | at high | -95.8% | -85.3% |
Inhibikase Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6600.00(0.0%) | $26.40 K(0.0%) |
| June 2024 | - | $6600.00(0.0%) | $26.40 K(-85.3%) |
| Mar 2024 | - | $6600.00(0.0%) | $179.00 K(+0.9%) |
| Dec 2023 | $177.40 K | $6600.00(0.0%) | $177.40 K(+0.9%) |
| Sept 2023 | - | $6600.00(-95.9%) | $175.80 K(+2.9%) |
| June 2023 | - | $159.20 K(+3084.0%) | $170.90 K(+1360.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $5000.00(0.0%) | $11.70 K(+74.6%) |
| Dec 2022 | $6700.00(>+9900.0%) | $5000.00(+194.1%) | $6700.00(+294.1%) |
| Sept 2022 | - | $1700.00(>+9900.0%) | $1700.00(>+9900.0%) |
| June 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2021 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2021 | - | $0.00 | $0.00 |
FAQ
- What is Inhibikase Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics annual D&A year-on-year change?
- What is Inhibikase Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics quarterly D&A year-on-year change?
- What is Inhibikase Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics TTM D&A year-on-year change?
What is Inhibikase Therapeutics annual depreciation & amortization?
The current annual D&A of IKT is $177.40 K
What is the all time high annual D&A for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high annual depreciation & amortization is $177.40 K
What is Inhibikase Therapeutics annual D&A year-on-year change?
Over the past year, IKT annual depreciation & amortization has changed by +$170.70 K (+2547.76%)
What is Inhibikase Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of IKT is $6600.00
What is the all time high quarterly D&A for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high quarterly depreciation & amortization is $159.20 K
What is Inhibikase Therapeutics quarterly D&A year-on-year change?
Over the past year, IKT quarterly depreciation & amortization has changed by $0.00 (0.00%)
What is Inhibikase Therapeutics TTM depreciation & amortization?
The current TTM D&A of IKT is $26.40 K
What is the all time high TTM D&A for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high TTM depreciation & amortization is $179.00 K
What is Inhibikase Therapeutics TTM D&A year-on-year change?
Over the past year, IKT TTM depreciation & amortization has changed by -$149.40 K (-84.98%)